Systemic Administration of Calea pinnatifida Inhibits Inflammation Induced by Carrageenan in a Murine Model of Pulmonary Neutrophilia

Mediators Inflamm. 2020 Jan 25:2020:4620251. doi: 10.1155/2020/4620251. eCollection 2020.

Abstract

Objective: The aim of this study was to investigate the anti-inflammatory effects of the crude extract (CE), derived fraction, and isolated compounds from Calea pinnatifida leaves in a mouse model of pulmonary neutrophilia.

Methods: The CE and derived fractions, hexane, ethyl acetate, and methanol, were obtained from C. pinnatifida leaves. The compounds 3,5- and 4,5-di-O-E-caffeoylquinic acids were isolated from the EtOAc fraction using chromatography and were identified using infrared spectroscopic data and nuclear magnetic resonance (1H and 13C NMR). Leukocytes count, protein concentration of the exudate, myeloperoxidase (MPO) and adenosine deaminase (ADA), and nitrate/nitrite (NO x ), tumor necrosis factor-alpha (TNF-α), interleukin-1-beta (IL-1β), and interleukin-17A (IL-17A) levels were determined in the pleural fluid leakage after 4 h of pleurisy induction. We also analyzed the effects of isolated compounds on the phosphorylation of both p65 and p38 in the lung tissue.

Results: The CE, its fractions, and isolated compounds inhibited leukocyte activation, protein concentration of the exudate, and MPO, ADA, NO x , TNF-α, IL-1β, and IL-17A levels. 3,5- and 4,5-di-O-E-caffeoylquinic acids also inhibited phosphorylation of both p65 and p38 (P < 0.05).

Conclusion: This study demonstrated that C. pinnatifida presents important anti-inflammatory properties by inhibiting activated leukocytes and protein concentration of the exudate. These effects were related to the inhibition of proinflammatory mediators. The dicaffeoylquinic acids may be partially responsible for these anti-inflammatory properties through the inhibition of nuclear transcription factor kappa B and mitogen-activated protein kinase pathways.

MeSH terms

  • Adenosine Deaminase / metabolism
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Asteraceae / chemistry*
  • Carrageenan
  • Disease Models, Animal
  • Female
  • Inflammation / chemically induced
  • Inflammation / drug therapy*
  • Interleukin-17 / metabolism
  • Interleukin-1beta / metabolism
  • Leukocyte Disorders / chemically induced
  • Leukocyte Disorders / drug therapy*
  • Lung / drug effects
  • Lung / metabolism
  • Lung / pathology
  • Lung Diseases / chemically induced
  • Lung Diseases / drug therapy*
  • Mice
  • Neutrophils / drug effects*
  • Nitrates / chemistry
  • Nitrites / chemistry
  • Peroxidase / metabolism
  • Phosphorylation
  • Plant Extracts / pharmacology*
  • Pleurisy / drug therapy
  • Quinic Acid / analogs & derivatives
  • Quinic Acid / chemistry
  • Transcription Factor RelA / metabolism
  • Tumor Necrosis Factor-alpha / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Anti-Inflammatory Agents
  • Interleukin-17
  • Interleukin-1beta
  • Nitrates
  • Nitrites
  • Plant Extracts
  • Rela protein, mouse
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • caffeoylquinic acid
  • Quinic Acid
  • Carrageenan
  • Peroxidase
  • p38 Mitogen-Activated Protein Kinases
  • Adenosine Deaminase